Distinguished in Neonatal Hemochromatosis

Vincent Guigonis

Limoges, FR 
Distinguished in Neonatal Hemochromatosis
Limoges, FR 
OverviewLocationsClinical Research

Overview

Vincent Guigonis practices in Limoges, France. Mr. Guigonis is rated as a Distinguished expert by MediFind in the treatment of Neonatal Hemochromatosis. His top areas of expertise are Neonatal Hemochromatosis, Nephrotic Syndrome, Bartter Syndrome, and Caffey Disease.

His clinical research consists of co-authoring 72 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 1 clinical trial in the study of Neonatal Hemochromatosis.

Gender
Male

Locations

Limoges, France
Other Locations
Bordeaux, France
8, Avenue Dominique Larrey 87000 Limoges, Larrey, 87000, France
Nantes, 44093, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury
Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury
Enrollment Status: Terminated
Publish Date: April 15, 2021
Intervention Type: Procedure
Early Treatment With the Monoclonal C5 Antibody Eculizumab in Pediatric Patients Affected by Shiga-toxin Related Hemolytic and Uremic Syndrome: A Phase III Prospective Randomized Controlled Therapeutic Trial Versus Placebo
Early Treatment With the Monoclonal C5 Antibody Eculizumab in Pediatric Patients Affected by Shiga-toxin Related Hemolytic and Uremic Syndrome: A Phase III Prospective Randomized Controlled Therapeutic Trial Versus Placebo
Enrollment Status: Completed
Publish Date: July 12, 2019
Intervention Type: Drug
Study Phase: Phase 3
Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Enrollment Status: Completed
Publish Date: January 15, 2019
A Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function
A Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function
Enrollment Status: Active_not_recruiting
Publish Date: August 13, 2018
View 3 Less Clinical Trials

72 Total Publications

Reflections on the Use of Mycophenolate Mofetil in Pediatric Nephrotic Syndrome.
Reflections on the Use of Mycophenolate Mofetil in Pediatric Nephrotic Syndrome.
Journal: JAMA pediatrics
Published: August 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guigonis's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile